Financhill
Back

Global Blood Therapeutics Stock Predictions

Sell
50

GBT
Global Blood Therapeutics

Last Price:
68.21
Seasonality Move:
1.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Global Blood Therapeutics Stock Forecast

  • Over the next 52 weeks, Global Blood Therapeutics has on average historically fallen by 0.3% based on the past 6 years of stock performance.
  • Global Blood Therapeutics has fallen lower in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Global Blood Therapeutics Stock Undervalued?
    The current Global Blood Therapeutics [GBT] share price is $68.07. The Score for GBT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GBT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Global Blood Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Global Blood Therapeutics has on average historically fallen by 0.3% based on the past 6 years of stock performance.

Global Blood Therapeutics Stock Rating

Sell
50
Global Blood Therapeutics (GBT) is a Sell

Is Global Blood Therapeutics overpriced?

  • Global Blood Therapeutics has fallen lower in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Global Blood Therapeutics Stock Price History

Is GBT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBT is experiencing slight buying pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
gbt.com

52-Week Data

52-Week High:
73.02
52-Week Low:
21.65

Prediction Charts

Market Cap:
4.59B
Price in USD:
68.07
Volume:
2.08M
Beta:
0.87

Technical Analysis

SMA50:
60.31
SMA100:
44.24
SMA200:
37.57
52-Wk Change:
163.84%

Stock Predictions

  • Is Global Blood Therapeutics stock public?
    Yes, Global Blood Therapeutics is a publicly traded company.
  • What is the Global Blood Therapeutics stock quote today?
    The Global Blood Therapeutics stock price isĀ 68.07 USD today.
  • How to buy Global Blood Therapeutics stock online?
    You can buy Global Blood Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-12 67.86 67.87 67.93 67.74
Sep-13 67.78 67.75 67.98 67.75
Sep-14 67.80 67.95 67.95 67.70
Sep-15 67.85 67.78 67.89 67.66
Sep-16 67.71 67.62 67.78 67.54
Sep-19 67.69 68.03 68.03 67.61
Sep-20 67.87 67.89 68.15 67.76
Sep-21 67.92 67.69 68.20 67.65
Sep-22 67.78 67.97 68.09 67.67
Sep-23 67.91 67.99 68.04 67.83
Sep-26 67.92 67.75 68.13 67.74
Sep-27 67.90 68.18 68.19 67.85
Sep-28 68.14 68.11 68.19 67.95
Sep-29 68.11 68.07 68.19 67.79

Global Blood Therapeutics Earnings

Global Blood Therapeutics Earnings Report: Per Share Global Blood Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Global Blood Therapeutics Forecast Revenue Growth

Global Blood Therapeutics Stock Analysis: Historical quarterly revenues per share for Global Blood Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $1.88 per share.

* Global Blood Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.